Recent news on Desferal

FDA says Novartis iron-overload drug Exjade may lead to kidney ...  -  May 22, 2007
Forbes,The oral medication offers an alternative to previous treatments, including Novartis' own Desferal, which required an infusion which can last up to 8-12

New data support long term use of once – daily Exjade® to reduce ...  -  Mar 13, 2007
ArabianBusiness.com,Exjade was developed to meet the high unmet need for an oral iron chelator despite the availability of deferoxamine (Desferal).

Premarital tests important to avoid transmitting thalassemia to child  -  Dec 10, 2006
Kuwait News Agency,She explained that to help remove excess iron, patients undergo the difficult and painful infusion of a drug, Desferal. A needle is attached to a small

New Once-Daily, Oral Iron Chelator Provides Life-Altering ...  Oct 31, 2006
...in adults and children aged six years and older, as well as in children aged two to five who cannot be adequately treated with Desferal* (deferoxamine). ... -DG News A new once-daily, oral iron chelator provides a life-altering ...  Oct 31, 2006
...in adults and children aged six years and older, as well as in children aged two to five who cannot be adequately treated with Desferal(*)(deferoxamine). ... -Canada NewsWire (press release), Bulgarian Doctor Treats Brain Tumors With Rabies Vaccine  Oct 12, 2006
...metabolism. After his discovery he started treating his patients with the Desferal medicine because it clear aluminum of the blood. ... -Sofia News Agency, International Approvals: Coversyl, Exjade, and Loramyc  Oct 27, 2006
The once-daily treatment is also indicated for use when desferrioxamine (Desferal, made by Novartis) is contraindicated or considered inadequate for patients ... -Medscape (subscription) Exjade (Deferasirox), a Breakthrough Once-Daily Oral Iron Chelator ...  Sep 21, 2006
...desferrioxamine (Desferal(R)), which showed that after one year of treatment with comparable doses, Exjade produced similar reductions in liver iron ... -DG News

UPDATE: Novartis Gets EU Approval For Promising Exjade  Aug 30, 2006
Exjade, a tablet that is dissolved in a glass of juice or water, provides similar benefits to patients as Desferal, another Novartis drug that is today's ... -Easy Bourse (Communiqués de presse)

Novartis drinks to Exjade after EU approval  Sep 6, 2006
...therapy according to Novartis, Exjade, already available in the US, is administered once-daily as a drink, as opposed to the company's Desferal, which requires ... -In-PharmaTechnologist.com

Exjade, For Patients With Transfusional Iron Overload, Gains ...  Sep 2, 2006
The main Phase III study showed that when dosed appropriately, Exjade was as effective as deferoxamine (Desferal) in reducing iron burden. ... -Medical News Today

UPDATE 3-EU approves Novartis's Exjade iron overload drug  Aug 30, 2006
Novartis developed Exjade, an oral tablet that dissolves in water, as an alternative to its current treatment Desferal, which is given by infusion. ... -Reuters

Premarital tests important to avoid transmitting thalassemia to ...  -  Dec 10, 2006
Kuwait News Agency,...needs. She explained that to help remove excess iron, patients undergo the difficult and painful infusion of a drug, Desferal. A ...

Lebanon situation report No. 22  Aug 9, 2006
Further WHO shipments of chronic disease medicines and desferal for thalassemia patients arrived in Beirut and were distributed through the Ministry of Public ... -ReliefWeb

Ferriprox Prevents Heart Failure Deaths In Thalassaemia  Jul 17, 2006
...study show Ferriprox, an oral bidentate hydropyroxidine, compared very favourably against the standard chelation therapy Desferal (deferoxamine) administered ... -Medical News Today



Genetic disease detectable, doctors say  May 9, 2006
However, in order to prevent an accumulation of iron in the body due to the constant blood transfusion, doctors recommend injections of Desferal to help the ... - Taiwan Headlines

Adolescent screening can save many a life  May 7, 2006
...‘‘Three children died due to cardiac problems at the Medical College last year, as the medicines that prevent iron deposit including Desferal, Exjade and ... - Newindpress (subscription)

Update in Environmental and Occupational Medicine 2005  May 2, 2006
...were inhibited by pretreatment with GdCl 3 (an inhibitor of macrophage activation), allopurinol (an inhibitor of xanthine oxidase), or Desferal (an iron ... - AJRCCM (subscription)

Repro-Med Retains Marketing and Sales Firm  Apr 21, 2006
...and may be used to deliver a wide range of infusion products including antibiotics, pain control, chemotherapy drugs, immune globulin, desferal, cardiac drugs ... - Yahoo! News





FDA approves Teva's generic Desferal for injection  Apr 2, 2006
Teva’s Deferoxamine Mesylate for injection is the AP-rated generic equivalent of Novartis’ Desferal for injection, a product indicated for acute treatment ... - Globes

Teva Gets FDA Nod for Novartis Generic  Apr 3, 2006
The FDA has granted approval for Teva's generic equivalent of Novartis' Desferal for injection, a product indicated for acute treatment of iron intoxication ... - International News Service

Teva Receives FDA Approval For Deferoxamine Mesylate For Injection ...  Apr 2, 2006
Teva noted that its Deferoxamine Mesylate for Injection is the AP-rated generic equivalent of Novartis' Desferal for Injection. ... - Trading Markets

Teva Cleared for Iron Treatment  Apr 3, 2006
The product is the generic equivalent of Novartis' Desferal for injection, a product indicated for acute treatment of iron intoxication and chronic iron ... - TheStreet.com

Teva has FDA OK for generic Novartis injection  Apr 2, 2006
The product is the generic equivalent of Novartis's (NOVN.VX: Quote, Profile, Research) Desferal for injection, a product indicated for treatment of iron ... - Reuters

Teva Announces Approval of Deferoxamine Mesylate for Injection USP  Apr 2, 2006
Teva's Deferoxamine Mesylate for Injection is the AP-rated generic equivalent of Novartis' Desferal(R) for Injection, a product indicated for acute treatment ... - International News Service

New oral drug could make Thalassemia treatment less painful for ...  Feb 8, 2006
...these problems, children with Thalassemia major needed regular treatment to remove the excess iron from their bodies for which Desferal (R) (deferoxamine ... - Daily Times

To: National Desk  Jan 9, 2006
Speaking about his study, Dr Pennell said that it "shows that deferiprone clears iron from the heart more effectively than desferal, and improves heart function ... - U.S. Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional